In the UK, over 3 million people live with the most severe stages of kidney disease and this is rising rapidly. People with kidney disease face increased risk of heart attack or stroke. Risk factors, such as diabetes, CVD and obesity that contribute to kidney disease, are also growing.
The total annual economic burden of kidney disease in the UK is £7bn, with £6.4bn being direct costs to the NHS – about 3.2% of NHS budgets. (1)
People living with CKD and those who support them experience a dramatic impact in their daily lives, with £372m in productivity loss to the UK economy annually from missed work due to dialysis alone. This could rise to £2bn by 2033. (1)
All 15 health innovation networks across England are working together to roll out a successful care model to improve kidney care.
The LUCID – Connecting kidney care programme improves patient outcomes through early detection of chronic kidney disease (CKD), early intervention and optimisation, while maximising productivity and value for money.
Programme aims:
New economic analysis from health economists, Frontier Economics, commissioned by the Health Innovation Network highlights the massive potential that could be achieved by rolling out the programme across England:
In East of England, we are working with local providers to introduce the new programme.
The model bridges the gap between primary and secondary care by integrating management of CKD. It has four main principles:
– LUCID multi-disciplinary team meetings (MDTs) are established, ensuring a more joined-up approach between hospital and GP practice care teams.
– Steps are put in place to identify patients more at risk of kidney disease.
– Training is provided for clinicians, and patients are better informed and able to manage their care.
– Ongoing healthcare management is optimised.
For more information click here
The original LUCID programme was developed through a Joint Working Agreement between the John Walls Renal Unit at University Hospitals of Leicester NHS Trust and AstraZeneca UK. That Joint Working project has concluded, and AstraZeneca UK has now signed a Memorandum of Understanding with Health Innovation East Midlands to share expertise and insights on the future implementation and scaling of LUCID.
References
(1) https://www.kidneyresearchuk.org/about-us/policy/health-economics-report/
Do you have a great idea that could deliver meaningful change in the real world?
Get involved